SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011149
Filing Date
2021-08-10
Accepted
2021-08-10 16:31:57
Documents
54
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aptx-20210630x10q.htm   iXBRL 10-Q 1127817
2 EX-31.1 aptx-20210630xex31d1.htm EX-31.1 21683
3 EX-31.2 aptx-20210630xex31d2.htm EX-31.2 21860
4 EX-32.1 aptx-20210630xex32d1.htm EX-32.1 11059
5 GRAPHIC aptx-20210630x10q001.jpg GRAPHIC 430050
  Complete submission text file 0001558370-21-011149.txt   5468717

Data Files

Seq Description Document Type Size
6 EX-101.SCH aptx-20210630.xsd EX-101.SCH 27583
7 EX-101.CAL aptx-20210630_cal.xml EX-101.CAL 33517
8 EX-101.DEF aptx-20210630_def.xml EX-101.DEF 94363
9 EX-101.LAB aptx-20210630_lab.xml EX-101.LAB 257913
10 EX-101.PRE aptx-20210630_pre.xml EX-101.PRE 208954
11 EXTRACTED XBRL INSTANCE DOCUMENT aptx-20210630x10q_htm.xml XML 834364
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38535 | Film No.: 211160349
SIC: 2834 Pharmaceutical Preparations